In vitro 1H and 31P NMR spectroscopic evidence of multiple aberrant biochemical pathways in murine trisomy 16 brain development

International Journal of Developmental Neuroscience

Volumn 18, Issue 8, 2000, Pages 833-841

  Yao, Faith S ^a,b   Caserta, Maria T ^a,c   Wyrwicz, Alice M ^a,b,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b EVANSTON NORTHWESTERN HEALTHCARE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Down syndrome; myo Inositol; Nuclear magnetic resonance

Indexed keywords

ADENOSINE; CHOLINE; CREATINE; INOSITOL; INOSITOL PHOSPHATE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; TYROSINE; 4 AMINOBUTYRIC ACID; ALANINE; ASPARTIC ACID; BIOLOGICAL MARKER; GLUTAMIC ACID; INOSITOL 1,4,5 TRISPHOSPHATE; LACTIC ACID; PHOSPHORUS; PROTON; TAURINE; THREONINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; CONTROLLED STUDY; DOWN SYNDROME; FETUS; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TRISOMY; ANIMAL; BRAIN LEVEL; C57BL MOUSE; DISEASE MODEL; FEMALE; GENETICS; METABOLISM; MOUSE MUTANT;

ALANINE; ANIMALS; ASPARTIC ACID; BIOLOGICAL MARKERS; BRAIN CHEMISTRY; CHOLINE; CREATINE; DISEASE MODELS, ANIMAL; DOWN SYNDROME; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; INOSITOL 1,4,5-TRISPHOSPHATE; LACTIC ACID; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PHOSPHORUS ISOTOPES; PROTONS; TAURINE; THREONINE;

EID: 0034352547     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-5748(00)00043-5     Document Type: Article

References (53)

1. Application of stable isotope tracer combined with mass spectrometric detection for studying myo-inositol uptake by cultured neurons from fetal mouse: effect of trisomy 16
2. Neurochemical approaches to the pathogenesis of Down's syndrome
3. Certain neurochemical aspects of the pathogenesis of Down syndrome
4. Multinuclear NMR studies on the energy metabolism of glia and neuronal cells
5. 31P NMR profiles of Alzheimer's disease and multiple subcortical infarct dementia
6. Increased number of somatostatin-immunoreactive neurons in primary cultures of trisomy 16 mouse neocortex
7. Neuropeptide Y (NPY)-immunoreactive neurons in murine trisomy 16 cortical cultures: plasticity of expression and differentiation
8. Nerve growth factor corrects developmental impairments of basal forebrain cholinergic neurons in the trisomy 16 mouse
9. Apoptosis decision cascades and neuronal degeneration in Alzheimer's disease
10. The neurobiological consequences of Down syndrome
11. Molecular basis for membrane phospholipid diversity: why are there so many lipids?
12. myo-Inositol metabolites as cellular signals
13. 31P NMR at different compositions of the solvent system chloroform-methanol-water
14. Mouse trisomy 16: an animal model for human trisomy 21 (Down syndrome)
15. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages
16. A simple method for the isolation and purification of total lipids from animal tissues
17. Increased expression of voltage-activated calcium channels in cultured hippocampal neurons from mouse trisomy 16, a model for Down syndrome
18. Autosomal aneuploidy in mice: generation and developmental consequences
19. Differences in the metabolism of inositol and phosphoinositides by cultured cells of neuronal and glial origin
20. Alzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue
21. Morphogenesis of the brain and craniofacial complex in trisomy 16 mice
22. Consequences of trisomy 16 for mouse brain development: corticogenesis is a model of Down syndrome
23. 1H MRS study
24. Selective retardation of the development of the basal forebrain cholinergic and pontine catecholaminergic nuclei in the brain of trisomy 16 mouse, an animal model of Down's syndrome
25. Free choline and choline metabolites in rat brain and body fluids: sensitive determination and implications for choline supply to the brain
26. N-acetyle-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: a preliminary proton nuclear magnetic resonance study
27. Alzheimer's disease histologically proven studied by MRI and MRS: two cases
28. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging
29. Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy
30. Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease
31. In vivo proton magnetic resonance spectroscopy study on premature aging in adult Down's syndrome
32. Lipid asymmetry in membranes
33. The neurobiologic consequences of autosomal trisomy in mice and men
34. Neurochemical changes in murine trisomy 16: delay in cholinergic and catecholaminergic systems
35. Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging
36. 31P nuclear magnetic resonance studies of phosphoglyceride metabolism in developing and degenerating brain: preliminary observations
37. Murine trisomy 16 model of Down's syndrome: central nervous system electron microscopic observations
38. Amyloidosis in aging and Alzheimer's disease
39. Genetic basis for a mouse model of Down syndrome
40. Clinical applications of magnetic resonance spectroscopy
41. Down's syndrome: is there a decreased population of neurons?
42. 2+ signaling and mitochondrial deficiencies in hippocampal neurons of trisomy 16 mice: a model of Down's syndrome
43. Polyol profiles in Down syndrome
44. Brain accumulation of myo-inositol in the trisomy 16 mouse, an animal model of Down's syndrome
45. Role of increased cerebral myo-inositol in the dementia of Down syndrome
46. Morphologic and neurochemical studies of embryonic brain development in murine trisomy 16
47. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types
48. Evidence of arrest of neurogenesis and synaptogenesis in brains of patients with Down's syndrome
49. In vitro proton and phosphorus NMR spectroscopic analysis of murine (C57B1/6J) brain development
50. Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome
51. Alzheimer-like cholinergic deficiency in Down syndrome
52. Phospholipids in animal eukaryotic membranes. Transverse asymmetry and movement
53. Platelet procoagulant activity and microvesicle formation. Its putative role in hemostasis and thrombosis